How RSV manipulates the immune response in respiratory cells

by Jan Grabowski, TWINCORE

edited by Lisa Lock, reviewed by Robert Egan

Lisa Lock

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Associate Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infections, particularly in newborns and older adults. How the virus manages to evade the immune system and what changes it triggers in infected cells have not been fully understood. Researchers from TWINCORE, Center for Experimental and Clinical Infection Research, together with interdisciplinary colleagues from Würzburg, Regensburg, Braunschweig and Hannover, have now demonstrated how the virus interferes with the genetic program of respiratory cells, inhibits the immune response and disrupts cell function. They published their findings in the journal Science Advances.

According to estimates by the World Health Organization (WHO), about 3.6 million children worldwide require hospital treatment for RSV each year. For 100,000 of them, the infection is fatal. "How the virus causes damage in the epithelial cells of the respiratory tract and why the immune response does not keep it better in check has been unclear until now," says Prof. Thomas Pietschmann, director of the Institute for Experimental Virology at TWINCORE in Hannover and lead author of the study.

A lung-like model for infection

To answer this question, the researchers used a special cell culture model. They cultured respiratory cells from human donors, typically patients receiving a donor lung. "In the laboratory, these cells then grow together to form a lung-like ciliated epithelium, complete with ciliary beating and mucus production," explains Prof. Bettina Wiegmann from the Department of Cardiac, Thoracic, Transplant and Vascular Surgery at Hannover Medical School and a co-author of the study.

They then infected this tissue culture with RSV and subsequently analyzed gene activity in every single cell using RNA sequencing. "By comparing with uninfected cells, we can identify how thousands of genes are regulated by the infection," says Prof. Emmanuel Saliba, who heads the research group Single-Cell Analysis at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, a site of the Helmholtz Center for Infection Research in Braunschweig in cooperation with the Julius-Maximilians-Universität Würzburg.

When infected cells miss the alarm

"Our data show that only a fraction of the infected cells even realize they have been infected," says Dr. Sibylle Haid, a researcher at Pietschmann's institute and, together with Kevin Berg (Regensburg), first author of the study. "This is probably because only some lung cells produce sufficient quantities of virus detectors and thus generate messenger molecules quickly enough to protect themselves and neighboring cells."

If there are too few of these sensor molecules, the virus gains the upper hand, multiplies and then actively suppresses this protective mechanism. A key messenger substance in the immune system is interferon, which has both a direct antiviral effect and activates the so-called interferon-stimulated genes (ISGs).

"Even treating the cells with interferon cannot eliminate the virus at this stage," says Haid. With one exception: The team discovered that the antiviral transcription factor IRF1 is not suppressed by RSV and was then able to demonstrate that artificially activating this factor can suppress the RSV infection—at least in the simplified model.

The researchers also found a possible explanation for the cell damage caused by RSV. "In the infected epithelial cells, the genes that control cilia formation were also inhibited," says Haid. Cilia are the tiny hair-like structures on cells that are responsible, among other things, for clearing mucus. If this function is disrupted by the infection, the typical symptoms of the disease arise.

"In this study, we were able to gain important insights into the pathology of RSV infection at the cellular level and also identify IRF1 as a potentially promising candidate for pharmaceutical intervention," says Pietschmann. "This would not have been possible without the interdisciplinary collaboration with our partners."

Publication details

Kevin Berg et al, Respiratory syncytial viral load drives ciliated cell dedifferentiation and suppresses antiviral immunity, Science Advances (2026). DOI: 10.1126/sciadv.aed4499

Journal information: Science Advances

Key medical concepts

Respiratory Syncytial Viruses

Clinical categories

Infectious diseasesPulmonary medicineAllergy and immunology Provided by TWINCORE Who's behind this story?

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: How RSV manipulates the immune response in respiratory cells (2026, June 22) retrieved 22 June 2026 from https://medicalxpress.com/news/2026-06-rsv-immune-response-respiratory-cells.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.